Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- Barlogie Receives Distinction for Career of Fighting Myeloma
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
- UAMS Neurosurgeon Receives Award Close to His Heart
June 7, 2004 | The first time Sam Al-Mefty, M.D., became interested in a type of brain tumor caused by radiation was when he met fellow neurosurgeon Steven Mahaley, M.D., in Saudi Arabia.
- New Dean of UAMS Graduate School Has Big Plans for the Future
McGehee says he wants to “razzle-dazzle” prospective UAMS graduate students. Recruiting potential students is just one of the goals he hopes to accomplish as the new dean of the University of Arkansas for Medical Sciences (UAMS) Graduate School.
- New Dean of UAMS Graduate School Has Big Plans for the Future
McGehee says he wants to “razzle-dazzle” prospective UAMS graduate students. Recruiting potential students is just one of the goals he hopes to accomplish as the new dean of the University of Arkansas for Medical Sciences (UAMS) Graduate School.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Medical Students Spend Summer Days Helping At-Risk Youth
JUNE 25, 2004 | Summer means a lot of things to different people, but for many college students it means relaxing by the pool, playing at the lake and enjoying not having to wake up early for classes. But for a group of medical students from the University of Arkansas for Medical Sciences (UAMS), summer means something entirely different – the chance to help underprivileged youth.
- UAMS Medical Students Spend Summer Days Helping At-Risk Youth
JUNE 25, 2004 | Summer means a lot of things to different people, but for many college students it means relaxing by the pool, playing at the lake and enjoying not having to wake up early for classes. But for a group of medical students from the University of Arkansas for Medical Sciences (UAMS), summer means something entirely different – the chance to help underprivileged youth.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- U.S.News & World Report Names UAMS Among Best Hospitals
LITTLE ROCK – For the ninth consecutive year, UAMS Medical Center has been named by U.S.News & World Report to its annual list of “America’s Best Hospitals,” moving up four places from last year. UAMS is the only hospital in the state named to the list.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- Aubrey Hough, 2004 Distinguished Faculty Scholar, Talks Bioterrorism
AUG. 2, 2004 | Aubrey J. Hough, M.D., traced the use of bioterrorism through the ages in his lecture as the 2004 UAMS Distinguished Faculty Scholar. Hough, recently appointed Associate Dean for Translational Research and Special Projects, continues to focus his energies on initiating research programs in biodefense as well as the re-engineering of UAMS’ clinical research infrastructure.
- Aubrey Hough, 2004 Distinguished Faculty Scholar, Talks Bioterrorism
AUG. 2, 2004 | Aubrey J. Hough, M.D., traced the use of bioterrorism through the ages in his lecture as the 2004 UAMS Distinguished Faculty Scholar. Hough, recently appointed Associate Dean for Translational Research and Special Projects, continues to focus his energies on initiating research programs in biodefense as well as the re-engineering of UAMS’ clinical research infrastructure.
- Aubrey Hough, 2004 Distinguished Faculty Scholar, Talks Bioterrorism
AUG. 2, 2004 | Aubrey J. Hough, M.D., traced the use of bioterrorism through the ages in his lecture as the 2004 UAMS Distinguished Faculty Scholar. Hough, recently appointed Associate Dean for Translational Research and Special Projects, continues to focus his energies on initiating research programs in biodefense as well as the re-engineering of UAMS’ clinical research infrastructure.
- Transplant Surgeon to Help Launch the State’s First Liver Transplant Program at UAMS
AUG. 9, 2004 | Establishing a liver transplant program is nothing new to You Min Wu, M.D. Not only did he initiate a liver transplant program at an Iowa hospital, but he also introduced liver transplantation to his native country of China. Now, he will help launch the state’s first liver transplant program at the University of Arkansas for Medical Sciences (UAMS).
- Transplant Surgeon to Help Launch the State’s First Liver Transplant Program at UAMS
AUG. 9, 2004 | Establishing a liver transplant program is nothing new to You Min Wu, M.D. Not only did he initiate a liver transplant program at an Iowa hospital, but he also introduced liver transplantation to his native country of China. Now, he will help launch the state’s first liver transplant program at the University of Arkansas for Medical Sciences (UAMS).
- James Marsh, Internal Medicine Chair, Settles into New Job and State
AUG. 23, 2004 | Almost two months into his position as the new chair of the Department of Internal Medicine at the University of Arkansas for Medical Sciences (UAMS), James D. Marsh, M.D., says Arkansas is treating him well.
- James Marsh, Internal Medicine Chair, Settles into New Job and State
AUG. 23, 2004 | Almost two months into his position as the new chair of the Department of Internal Medicine at the University of Arkansas for Medical Sciences (UAMS), James D. Marsh, M.D., says Arkansas is treating him well.
- Freshmen White Coat Ceremony Imparts Importance of Integrity
AUG. 24, 2004 | The University of Arkansas for Medical Sciences (UAMS) held its White Coat Ceremony for freshmen College of Medicine students this month at the Robinson Center Exhibition Hall.
- Freshmen White Coat Ceremony Imparts Importance of Integrity
AUG. 24, 2004 | The University of Arkansas for Medical Sciences (UAMS) held its White Coat Ceremony for freshmen College of Medicine students this month at the Robinson Center Exhibition Hall.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- Myeloma Institute at UAMS Wins Nearly $18 Million Grant, Marks 5,000 Stem-Cell Transplants
AUG. 25, 2004 | LITTLE ROCK – The Myeloma Institute for Research and Therapy (MIRT), a part of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS), has received a National Cancer Institute (NCI) grant worth nearly $18 million – one of the largest awards ever given to UAMS.
- UAMS ANGELS Prenatal Program Receives National Innovation Award
SEPT. 2, 2004 | ANGELS, a University of Arkansas for Medical Sciences (UAMS) program to improve regional prenatal care for high-risk pregnancies, has attracted national attention for its innovation.
- UAMS ANGELS Prenatal Program Receives National Innovation Award
SEPT. 2, 2004 | ANGELS, a University of Arkansas for Medical Sciences (UAMS) program to improve regional prenatal care for high-risk pregnancies, has attracted national attention for its innovation.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Hosts Free Skin Cancer Screenings
SEPT. 22, 2004 | More than 250 people received free skin cancer screenings recently at the University of Arkansas for Medical Sciences (UAMS), raising public awareness and identifying potential problems that otherwise may have gone unnoticed.
- UAMS Looks to Future Hospital, Growth, Chancellor Says in Annual State of the Campus Address
SEPT. 27, 2004 | Chancellor I. Dodd Wilson, M.D., proclaimed the University of Arkansas for Medical Sciences (UAMS) healthy and ready for the challenge of building a replacement for its 50-year-old hospital during his annual state of the campus speech Tuesday.
- UAMS Looks to Future Hospital, Growth, Chancellor Says in Annual State of the Campus Address
SEPT. 27, 2004 | Chancellor I. Dodd Wilson, M.D., proclaimed the University of Arkansas for Medical Sciences (UAMS) healthy and ready for the challenge of building a replacement for its 50-year-old hospital during his annual state of the campus speech Tuesday.
- UAMS Fitness Center Kicks Off with an Aerobic Celebration
Oct. 8, 2004 | Hearts were pumping and feet were moving at the recent opening of the new University of Arkansas for Medical Sciences (UAMS) Fitness Center – and that was before the exercising even began.
- UAMS Fitness Center Kicks Off with an Aerobic Celebration
Oct. 8, 2004 | Hearts were pumping and feet were moving at the recent opening of the new University of Arkansas for Medical Sciences (UAMS) Fitness Center – and that was before the exercising even began.
- UAMS celebrates opening of Westside Campus in historic district
OCT. 14, 2004 | The University of Arkansas for Medical Sciences (UAMS) Department of Pediatrics marked the opening of its new Westside Campus at 1301 Wolfe St. in Little Rock with a recent open house at the facility, which is located in the former West Side Junior High School.
- UAMS celebrates opening of Westside Campus in historic district
OCT. 14, 2004 | The University of Arkansas for Medical Sciences (UAMS) Department of Pediatrics marked the opening of its new Westside Campus at 1301 Wolfe St. in Little Rock with a recent open house at the facility, which is located in the former West Side Junior High School.
- UAMS celebrates opening of Westside Campus in historic district
OCT. 14, 2004 | The University of Arkansas for Medical Sciences (UAMS) Department of Pediatrics marked the opening of its new Westside Campus at 1301 Wolfe St. in Little Rock with a recent open house at the facility, which is located in the former West Side Junior High School.
- UAMS surgeon performs successful implant of heart pump in child at ACH
OCT. 15, 2004 | Jonathan Drummond-Webb, M.D., chief of pediatric cardiovascular surgery and associate professor of surgery at the University of Arkansas for Medical Sciences (UAMS) College of Medicine and chief of pediatric cardiovascular surgery at Arkansas Children’s Hospital (ACH), led a surgical team that recently implanted a child with a newly developed miniature heart pump. The teen-ager, the second to receive the heart pump, is now the longest survivor after receiving the device.
- UAMS surgeon performs successful implant of heart pump in child at ACH
OCT. 15, 2004 | Jonathan Drummond-Webb, M.D., chief of pediatric cardiovascular surgery and associate professor of surgery at the University of Arkansas for Medical Sciences (UAMS) College of Medicine and chief of pediatric cardiovascular surgery at Arkansas Children’s Hospital (ACH), led a surgical team that recently implanted a child with a newly developed miniature heart pump. The teen-ager, the second to receive the heart pump, is now the longest survivor after receiving the device.
- UAMS surgeon performs successful implant of heart pump in child at ACH
OCT. 15, 2004 | Jonathan Drummond-Webb, M.D., chief of pediatric cardiovascular surgery and associate professor of surgery at the University of Arkansas for Medical Sciences (UAMS) College of Medicine and chief of pediatric cardiovascular surgery at Arkansas Children’s Hospital (ACH), led a surgical team that recently implanted a child with a newly developed miniature heart pump. The teen-ager, the second to receive the heart pump, is now the longest survivor after receiving the device.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- Blass lecture series hosts cancer genetics researcher
OCT. 15, 2004 | Examining the genetic mechanisms that differentiate us all could lead to selective cancer treatments, said researcher Frank J. Rauscher III, Ph.D., as he delivered the third Elizabeth Weitzenhoffer Blass Lecture in Cancer Genetics at the University of Arkansas for Medical Sciences (UAMS) on Oct. 11.
- ACRC celebrates 15 years of providing hope, cure and life
OCT. 20, 2004 | Custom-made omelets and birthday cake marked a week of festivities for patients, families and employees Oct. 11-15 as they celebrated the 15th anniversary of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS).
- ACRC celebrates 15 years of providing hope, cure and life
OCT. 20, 2004 | Custom-made omelets and birthday cake marked a week of festivities for patients, families and employees Oct. 11-15 as they celebrated the 15th anniversary of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS).
- ACRC celebrates 15 years of providing hope, cure and life
OCT. 20, 2004 | Custom-made omelets and birthday cake marked a week of festivities for patients, families and employees Oct. 11-15 as they celebrated the 15th anniversary of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS).
- ACRC celebrates 15 years of providing hope, cure and life
OCT. 20, 2004 | Custom-made omelets and birthday cake marked a week of festivities for patients, families and employees Oct. 11-15 as they celebrated the 15th anniversary of the Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS).
- UAMS Researcher’s Work Extends Beyond Possible Osteoporosis Cure
OCT. 22, 2004 | Stavros Manolagas, M.D., Ph.D., professor of medicine in the College of Medicine at the University of Arkansas for Medical Sciences (UAMS) and his research team at UAMS and the Central Arkansas Veterans Healthcare System remain on the forefront of finding a possible cure not only for bone-weakening osteoporosis but other diseases as well.
- UAMS Researcher’s Work Extends Beyond Possible Osteoporosis Cure
OCT. 22, 2004 | Stavros Manolagas, M.D., Ph.D., professor of medicine in the College of Medicine at the University of Arkansas for Medical Sciences (UAMS) and his research team at UAMS and the Central Arkansas Veterans Healthcare System remain on the forefront of finding a possible cure not only for bone-weakening osteoporosis but other diseases as well.
- Rayford Remembered for Gentle Heart, Desire for Excellence During Dedication of Auditorium, Endowed Scholarship
Nov. 1, 2004 | Colleagues, students, friends and family celebrated the life and work of Phillip Leon Rayford, Ph.D., Thursday, packing the auditorium of the Biomedical Research Center Building II, which was dedicated in honor of the former chairman of the Department of Physiology and Biophysics and former associate dean for minority affairs at the University of Arkansas for Medical Sciences (UAMS).
- Rayford Remembered for Gentle Heart, Desire for Excellence During Dedication of Auditorium, Endowed Scholarship
Nov. 1, 2004 | Colleagues, students, friends and family celebrated the life and work of Phillip Leon Rayford, Ph.D., Thursday, packing the auditorium of the Biomedical Research Center Building II, which was dedicated in honor of the former chairman of the Department of Physiology and Biophysics and former associate dean for minority affairs at the University of Arkansas for Medical Sciences (UAMS).
- Rayford Remembered for Gentle Heart, Desire for Excellence During Dedication of Auditorium, Endowed Scholarship
Nov. 1, 2004 | Colleagues, students, friends and family celebrated the life and work of Phillip Leon Rayford, Ph.D., Thursday, packing the auditorium of the Biomedical Research Center Building II, which was dedicated in honor of the former chairman of the Department of Physiology and Biophysics and former associate dean for minority affairs at the University of Arkansas for Medical Sciences (UAMS).
- Symphony quartets perform at UAMS
NOV. 1, 2004 | Two quartets of the Arkansas Symphony Orchestra delivered a stirring performance for an appreciative crowd on Oct. 28 at the University of Arkansas for Medical Sciences (UAMS) as part of the Dr. Ruth Marie Allen Concert Series.
- Symphony quartets perform at UAMS
NOV. 1, 2004 | Two quartets of the Arkansas Symphony Orchestra delivered a stirring performance for an appreciative crowd on Oct. 28 at the University of Arkansas for Medical Sciences (UAMS) as part of the Dr. Ruth Marie Allen Concert Series.
- UAMS Celebrates Plans for New Psychiatry Center
NOV. 3, 2004 | The University of Arkansas for Medical Sciences (UAMS) recently recognized supporters of its efforts to build a new psychiatry center with a luncheon on Oct. 11 in their honor.
- UAMS Celebrates Plans for New Psychiatry Center
NOV. 3, 2004 | The University of Arkansas for Medical Sciences (UAMS) recently recognized supporters of its efforts to build a new psychiatry center with a luncheon on Oct. 11 in their honor.
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Grammy winner Jarreau headlines annual benefit for ACRC
NOV. 5, 2004 | Five-time Grammy winner Al Jarreau gave guests at the ninth annual Arkansas Cancer Research Center’s Gala for Life a memorable evening of entertainment in celebration of the work done by the ACRC at the University of Arkansas for Medical Sciences (UAMS).
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
Sept. 13, 2004 | The Marie Denise DeBartolo York Foundation has made a gift of $1.5 million to the University of Arkansas for Medical Sciences (UAMS) to establish the Aubrey J. Hough Jr., M.D., Endowed Chair in Pathology and the John and Denise DeBartolo York Chief Residency in Pathology.
The chair is named in honor of Aubrey J. Hough, M.D., a distinguished professor in the Department of Pathology who chaired the department for more than 21 years and served two terms as UAMS Medical Center chief of staff. Hough, a Little Rock native, is also associate dean for translational research and special projects in the UAMS College of Medicine and was recently named the College of Medicine Distinguished Faculty Scholar – the highest honor a faculty member at the UAMS College of Medicine can receive.
Bruce Smoller, M.D., current chair of the Department of Pathology in the College of Medicine at UAMS, has been selected as the first holder of the Hough Chair.
“We are very grateful to Dr. and Mrs. York for their support of UAMS and this chair in honor of Dr. Hough, whose contributions have made an enormous impact on our institution and on the practice of medicine,” said UAMS Chancellor I. Dodd Wilson, M.D. “Their gift will not only help support the work of our faculty in the field of pathology through the Hough chair, but also will help us better prepare the pathologists of tomorrow through the establishment of the York Chief Residency in Pathology.”
Smoller is a professor of pathology and dermatology in the College of Medicine and director of the dermatopathology program. He became chair of the department in January. Smoller is internationally known for his studies of the pathology of cutaneous malignant lymphoma and has held numerous national posts in his specialty.
“The generosity of John and Denise York will make it possible for us to continue our excellent clinical service, award winning residency-training program in pathology and resident-centered research endeavors,” said Smoller. “I am humbled to be the first recipient of this chair and especially since it is named for Aubrey Hough, one of the most brilliant physicians in his field.”
Denise DeBartolo York has received accolades as one of the most successful business women in the United States. She serves as chairman of The DeBartolo Corporation, a professional sports/entertainment and investment business, and oversees the Corporation’s portfolio, including the five-time world champion San Francisco 49ers. John York doubles as President of the DeBartolo Corporation and handles the day-to-day operations of the San Francisco 49ers. A successful entrepreneur with a multi-faceted business and medical background, York practiced Hematopathology through 1996, specializing in the diagnosis of leukemia and lymphomas.
According to York, “Aubrey Hough, my Pathology Professor at the VA Hospital in Nashville, Tenn., and close mentor, was instrumental with my decision to pursue and research the diseases that have such a tragic effect on our society. He’s a brilliant man, and by sharing his knowledge he is helping so many others.”
The UAMS Pathology Department provides residency training in surgical pathology, autopsy pathology, orthopedic pathology, dermatopathology, nephropathology, neuropathology, ultrastructural pathology, immunopathology and molecular biology, cytopathology and fine needle aspiration, laboratory hematology and hematopathology, immunology, blood banking and apheresis, special coagulation, cytogenetics and molecular pathology, pediatric pathology and forensic pathology.
The tradition of establishing endowed chairs at universities is the highest academic honor that can be bestowed upon distinguished faculty of an academic institution and the practice is steeped in history. The first named chair was established in England in 1502, when Lady Margaret Beaufort, mother of the Earl of Richmond (by then Henry VII) donated the Lady Margaret Professorship of Divinity to Cambridge.
Today, almost five centuries later, her gift still supports a continuous line of distinguished scholars – the Margaret Professors. English settlers introduced the practice to America. The first endowed chair in America was established at Harvard University 50 years before the American Revolution. That institution now has more than 200 chairs.
A single gift or a group of designated gifts totaling $1 million or more creates an endowed chair at UAMS. The Hough Endowed Chair in Pathology makes 37 endowed chairs at UAMS.
|